UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047445
Receipt number R000054101
Scientific Title Non-recessive randomized controlled trial under OLED illumination - Randomized crossover controlled trial
Date of disclosure of the study information 2022/04/09
Last modified on 2022/07/08 08:55:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Non-recessive randomized controlled trial under OLED illumination - Randomized crossover controlled trial

Acronym

Non-recessive randomized controlled trial under OLED illumination - Randomized crossover controlled trial

Scientific Title

Non-recessive randomized controlled trial under OLED illumination - Randomized crossover controlled trial

Scientific Title:Acronym

Non-recessive randomized controlled trial under OLED illumination - Randomized crossover controlled trial

Region

Japan


Condition

Condition

healthy subject

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

It has been clarified that OLED lighting is not inferior to general lighting in night workability even in dark places.

Basic objectives2

Others

Basic objectives -Others

Non-inferiority test

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Uchida-Kraepelin test(average number of answer)

Key secondary outcomes

average number of error, Karolinska sleepiness scale, KSS


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

irradiate for 30 minutes (at rest), rest for 5 minutes, and irradiate for 120 minutes (at work) under the study lighting environment, respectively.

Interventions/Control_2

irradiate for 30 minutes (at rest), rest for 5 minutes, and irradiate for 120 minutes (at work) under the control lighting environment, respectively.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

49 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Japanese men and women between 20 and 50 years old at the time of obtaining consent
2) Healthy people who have not received any treatment
3) Designated visits, items that can fill in records
4) Those with general computing power
5) With a normal sleep of 7 hours or more
6) Those who have received sufficient explanations about the purpose and content of the examination and agree to participate in writing at will

Key exclusion criteria

1) Visual abnormalities *Colorblind, color weakness or eye disease
2) Lasik surgery/ Glasses, eye vision correction with contact lenses
3) Pregnant and lactating
4) Irregular lifestyle habits
5) Drinking more than 20 g per day
6) With more than 20 smoking per day
7) Foods for specified health use, foods with functional indications, and other foods that cannot be refrained from consuming so-called health foods during the study period
8) Participation in other clinical trials or clinical trials within the last month

Target sample size

35


Research contact person

Name of lead principal investigator

1st name Youichi
Middle name KANEKA CORPORATION
Last name Yamaguchi

Organization

KANEKA CORPORATION

Division name

OLED Lighting Design & Planning Team Center of Business Group OLED Business Development Project

Zip code

107-6090

Address

1-12-32,Akasaka,Minato-ku Tokyo

TEL

03-5574-8000

Email

youichi.yamaguchi1@kaneka.co.jp


Public contact

Name of contact person

1st name Soichi
Middle name
Last name Yoneda

Organization

Mibyou Life Science Inc.

Division name

Clinical Trial Division

Zip code

101-0061

Address

5F Tokuei Bldg., Kanda Misaki-cho, Chiyoda-ku, Tokyo, Japan

TEL

03-6256-9600

Homepage URL


Email

renraku@mibyou-ls.com


Sponsor or person

Institute

Mibyou Life Science Inc.

Institute

Department

Personal name



Funding Source

Organization

KANEKA CORPORATION

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Mibyou Research Ethics Review Committee

Address

2-18-4 Kandamisakicho,Chiyoda-ku, Tokyo

Tel

03-6272-9163

Email

renraku@npo-mibyou.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

カネカ未来創造館(兵庫県)/Kaneka miraisouzoukan (Hyogo prefecture)


Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

32

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 03 Month 23 Day

Date of IRB

2022 Year 03 Month 31 Day

Anticipated trial start date

2022 Year 04 Month 12 Day

Last follow-up date

2022 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 04 Month 09 Day

Last modified on

2022 Year 07 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054101


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name